Join us on the path to curing GRIN2B Related Neurodevelopmental Disorder

2BCured is a partnership between parents and trailblazing experts committed to finding a cure and improving treatment options for GRIN2B Related Neurodevelopmental Disorder.

We're halfway to our goal of raising $8 million to
support the next 5 years of research.

Impact of GRIN2B disorder

The GRIN2B gene encodes receptors in the brain that are critical to learning and forming memories. Mutations in this gene can result in GRIN2B Related Neurodevelopmental Disorder. This devastating condition can render children completely dependent on their caregivers.

Common symptoms of GRIN2B disorder

Intellectual disabilit

Non-verbal and/or limited speech and communication abilities

Drug-resistant seizures

Features of Autism Spectrum Disorder and other conditions such as ADHD and schizophrenia

Gross and fine motor delays and disabilities

Gastrointestinal problems

Muscle tone abnormalities (spasticity and/or hypotonia)

There is currently no cure for GRIN2B Related Neurodevelopmental Disorder.

We're working to change that.

Meet Maisie

After a smooth delivery, Maisie faced breathing problems, low oxygen levels, and seizures, requiring six months in Neonatal Intensive Care. Genetic testing revealed a GRIN2B gene mutation. At three years old, she’s profoundly affected by GRIN2B Disorder, with severely limited mobility, vision impairment, a feeding tube, and drug-resistant epilepsy. Like many with the disorder, Maisie is entirely dependent on her caregivers.

Prof. Shai Berlin
We are proud to announce that we have recently developed — the first of its kind — genetic treatment for GRIN2B-related neurodevelopmental disorders. Our novel approach aims to restore normal NMDA-receptor activity, which is essential for proper brain development and neuronal communication. We will be presenting our results in the 7th Annual European GRIN Conference – Varese, Italy (October 17–19, 2025). Come and see us!!
Patent: TRDF 2024093-00; US provisional application | GKF Ref:. TECH-P-0306-USP
The image shows brain cells expressing the healthy GRIN2B gene (marked by a yellow color), which they received through gene therapy.